Plain-English translation of NCT06071845 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This study is testing a new minimally invasive device called the Cytosponge โ a small sponge on a string that you swallow to collect cells from your esophagus. Researchers want to see if the cells collected this way can be analyzed using a test called the Oncoguard Esophagus test to detect Barrett's esophagus and early warning signs of cancer. The goal is to offer people a simpler, safer alternative to traditional endoscopy (a procedure where a camera is passed down your throat).
Barrett's esophagus is a condition where acid reflux damages the lining of your esophagus and can increase cancer risk, but it's often detected only through invasive endoscopy. This trial exists to see if a simpler, less invasive sponge device could be an easier way for doctors to screen patients and catch this condition earlier.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you will swallow the Cytosponge device, which collects cells from your esophagus, and then it will be retrieved and sent to a laboratory for analysis. You will also complete standard care endoscopy and fill out questionnaires about your experience, including how comfortable the sponge procedure was and whether it caused any irritation. The study compares results between people with known or suspected Barrett's esophagus and those without, to determine how accurate the test is.
AI-generated summary from trial data ยท Jun 4, 2026 ยท Not medical advice
United States